Mukai, Hirofumi http://orcid.org/0000-0002-9292-5128
Yamaguchi, Takeshi
Takahashi, Masato
Hozumi, Yasuo
Fujisawa, Tomomi
Ohsumi, Shozo
Akabane, Hiromitsu
Nishimura, Reiki
Takashima, Tsutomu
Park, Youngjin
Sagara, Yasuaki
Toyama, Tatsuya
Imoto, Shigeru
Mizuno, Toshiro
Yamashita, Satoshi
Fujii, Satoshi
Uemura, Yukari
Article History
Received: 21 May 2019
Revised: 15 January 2020
Accepted: 12 March 2020
First Online: 2 April 2020
Ethics approval and consent to participate
: Written informed consent was obtained from each patient prior to entry into the study. The study was conducted in compliance with the principles of the declaration of Helsinki and local ethical and legal requirements. The protocol and informed consent were approved by the independent ethics committees or institutional review board of all participating sites. A full list of the ethical committees can be found in the supplementary information.
: None.
: The data generated and analysed during this study are available at UMIN-CTR as UMIN000007074.
: The authors declare no competing interests.
: This study was supported by the Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED.